Dec 7 (Reuters) - Orexo AB ORX.ST :
* OREXO ENTERS EXCLUSIVE LICENSE AND SUPPLY AGREEMENT WITH
ACCORD
HEALTHCARE FOR ZUBSOLV[® ]IN EUROPE
* OREXO WILL RECEIVE DOUBLE-DIGIT ROYALTIES ON FUTURE NET
SALES
* FIRST LAUNCHES ARE EXPECTED IN H2, 2021
* AGREEMENT COVERS 29 COUNTRIES IN EUROPE
* HAS ENTERED INTO AN EXCLUSIVE LICENSING AGREEMENT WITH
ACCORD
HEALTHCARE, FOR COMMERCIALISATION OF ZUBSOLV
* EXCLUSIVE LICENSING AGREEMENT WITH ACCORD HEALTHCARE, FOR
COMMERCIALISATION OF ZUBSOLV(®) AND NALOXONE SUBLINGUAL TABLET
Source text for Eikon: ID:nWkryx7hq
Further company coverage: ORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))